chr13-110209324-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001845.6(COL4A1):c.651+68A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.255 in 1,379,242 control chromosomes in the GnomAD database, including 47,565 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.26   (  5499   hom.,  cov: 32) 
 Exomes 𝑓:  0.25   (  42066   hom.  ) 
Consequence
 COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.422  
Publications
4 publications found 
Genes affected
 COL4A1  (HGNC:2202):  (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014] 
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
 - autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
 - microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
 - familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). 
BP6
Variant 13-110209324-T-C is Benign according to our data. Variant chr13-110209324-T-C is described in ClinVar as Benign. ClinVar VariationId is 1293042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.312  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.265  AC: 40175AN: 151768Hom.:  5491  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
40175
AN: 
151768
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.253  AC: 310833AN: 1227356Hom.:  42066   AF XY:  0.253  AC XY: 157043AN XY: 621300 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
310833
AN: 
1227356
Hom.: 
 AF XY: 
AC XY: 
157043
AN XY: 
621300
show subpopulations 
African (AFR) 
 AF: 
AC: 
7376
AN: 
27544
American (AMR) 
 AF: 
AC: 
12377
AN: 
38010
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
5608
AN: 
23794
East Asian (EAS) 
 AF: 
AC: 
1241
AN: 
38688
South Asian (SAS) 
 AF: 
AC: 
17398
AN: 
76680
European-Finnish (FIN) 
 AF: 
AC: 
16543
AN: 
52944
Middle Eastern (MID) 
 AF: 
AC: 
1336
AN: 
5200
European-Non Finnish (NFE) 
 AF: 
AC: 
236177
AN: 
912068
Other (OTH) 
 AF: 
AC: 
12777
AN: 
52428
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.497 
Heterozygous variant carriers
 0 
 10995 
 21990 
 32984 
 43979 
 54974 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 7222 
 14444 
 21666 
 28888 
 36110 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.265  AC: 40219AN: 151886Hom.:  5499  Cov.: 32 AF XY:  0.266  AC XY: 19775AN XY: 74240 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
40219
AN: 
151886
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
19775
AN XY: 
74240
show subpopulations 
African (AFR) 
 AF: 
AC: 
11164
AN: 
41426
American (AMR) 
 AF: 
AC: 
4884
AN: 
15272
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
845
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
235
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
1026
AN: 
4810
European-Finnish (FIN) 
 AF: 
AC: 
3378
AN: 
10524
Middle Eastern (MID) 
 AF: 
AC: 
72
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
18077
AN: 
67906
Other (OTH) 
 AF: 
AC: 
482
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.506 
Heterozygous variant carriers
 0 
 1518 
 3035 
 4553 
 6070 
 7588 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 414 
 828 
 1242 
 1656 
 2070 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
465
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.